PTGX position history
The shares of Protagonist Therapeutics (PTGX) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 330,222 shares, $5.9M, 1.1% of portfolio
- 2021 Q4: 342,000 shares, $12M, 2.5% of portfolio, Add +3.6%
- 2022 Q1: 251,500 shares, $6M, 1.8% of portfolio, Reduce −26.5%
- 2022 Q2: not held, Exit
- 2022 Q3: not held
- 2022 Q4: not held
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: 112,700 shares, $2.6M, 0.69% of portfolio, New
- 2024 Q1: 225,400 shares, $6.5M, 1.5% of portfolio, Add +100.0%
- 2024 Q2: 105,000 shares, $3.6M, 0.83% of portfolio, Reduce −53.4%
- 2024 Q3: 105,000 shares, $4.7M, 0.79% of portfolio
- 2024 Q4: 105,000 shares, $4.1M, 0.71% of portfolio
- 2025 Q1: 105,000 shares, $5.1M, 1.1% of portfolio
- 2025 Q2: 210,000 shares, $12M, 2.3% of portfolio, Add +100.0%
- 2025 Q3: 105,000 shares, $7M, 0.99% of portfolio, Reduce −50.0%
- 2025 Q4: 210,000 shares, $18M, 2.4% of portfolio, Add +100.0%
- 2026 Q1: 100,000 shares, $11M, 1.4% of portfolio, Reduce −52.4%
- 2026 Q2: 100,000 shares, $12M, 1.1% of portfolio
- 2026 Q3: 100,000 shares, $14M, 1.6% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|